Predictive Oncology Statistics
Total Valuation
POAI has a market cap or net worth of $9.67 million. The enterprise value is $8.99 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
POAI has 6.67 million shares outstanding. The number of shares has increased by 20.51% in one year.
| Current Share Class | 6.67M |
| Shares Outstanding | 6.67M |
| Shares Change (YoY) | +20.51% |
| Shares Change (QoQ) | +37.12% |
| Owned by Insiders (%) | 1.59% |
| Owned by Institutions (%) | 3.61% |
| Float | 6.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.69 |
| Forward PS | 1.95 |
| PB Ratio | 4.92 |
| P/TBV Ratio | 5.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.22.
| Current Ratio | 1.20 |
| Quick Ratio | 0.93 |
| Debt / Equity | 1.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -252.07 |
Financial Efficiency
Return on equity (ROE) is -201.46% and return on invested capital (ROIC) is -88.93%.
| Return on Equity (ROE) | -201.46% |
| Return on Assets (ROA) | -66.44% |
| Return on Invested Capital (ROIC) | -88.93% |
| Return on Capital Employed (ROCE) | -370.56% |
| Revenue Per Employee | $42,406 |
| Profits Per Employee | -$399,147 |
| Employee Count | 35 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.70 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.73% in the last 52 weeks. The beta is 1.26, so POAI's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | -57.73% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 50.84 |
| Average Volume (20 Days) | 483,660 |
Short Selling Information
The latest short interest is 626,653, so 9.40% of the outstanding shares have been sold short.
| Short Interest | 626,653 |
| Short Previous Month | 457,805 |
| Short % of Shares Out | 9.40% |
| Short % of Float | 9.55% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, POAI had revenue of $1.48 million and -$13.97 million in losses. Loss per share was -$2.91.
| Revenue | 1.48M |
| Gross Profit | 681,377 |
| Operating Income | -13.64M |
| Pretax Income | -14.78M |
| Net Income | -13.97M |
| EBITDA | -12.99M |
| EBIT | -13.64M |
| Loss Per Share | -$2.91 |
Full Income StatementBalance Sheet
The company has $3.08 million in cash and $2.40 million in debt, giving a net cash position of $681,938 or $0.10 per share.
| Cash & Cash Equivalents | 3.08M |
| Total Debt | 2.40M |
| Net Cash | 681,938 |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 1.97M |
| Book Value Per Share | 0.29 |
| Working Capital | 750,642 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.89 million and capital expenditures -$248,828, giving a free cash flow of -$13.14 million.
| Operating Cash Flow | -12.89M |
| Capital Expenditures | -248,828 |
| Free Cash Flow | -13.14M |
| FCF Per Share | -$1.97 |
Full Cash Flow StatementMargins
| Gross Margin | 45.91% |
| Operating Margin | -919.14% |
| Pretax Margin | -924.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |